Get smart & reliable public policy insights right in your inbox.
Featured
Research
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)
Objective: Describe temporal changes in outpatient Benzodiazepine (BDZ) initiation rates following Acute Ischemic Stroke (AIS) discharge among Medicare beneficiaries. Background: Despite recommendati
Evaluating the Concordance Between International Classification of Diseases, Tenth Revision Code, and Stroke Severity as Measured by the National Institutes of Health Stroke Scale (P1-5.013)
Objective: To use the National Institutes of Health Stroke Scale (NIHSS) as reported in Paul Coverdell Stroke Registry (PCSR) to assess the accuracy of the ICD-10-based NIHSS as a measure of Acute Isc
Biopharma Venture Capital And The Inflation Reduction Act
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in Medicare drug costs.
Substandard housing and the risk of COVID-19 infection and disease severity: A retrospective cohort study
In this study we examine associations between substandard housing and the risk of COVID-19 infection and severity during the first year of the pandemic by linking individual-level housing and clinical
Experts
Watch & Listen
Dr. Rochelle Walensky on making public health policy under fire
Former CDC Director Rochelle Walensky shares leadership lessons gleaned from making policy during a two year period dominated by pandemic anxiety, rapidly shifting science, and toxic politics.